Evelo is targeting the small intestinal axis with the goal of creating big change for those with inflammatory diseases and cancer
We have a variety of ongoing clinical trials in different therapeutic areas, which are detailed below. If you have questions, please contact firstname.lastname@example.org.
Phase 2 study investigating the effect of EDP1815 in the treatment of mild and moderate psoriasis.
Phase 1 study investigating the safety and tolerability of EDP1867 in healthy volunteers, participants with atopic dermatitis.
Phase 2 study of EDP1815 in atopic dermatitis coming in 3Q 2021.